Brief: Fate Therapeutics Reports First Quarter 2022 Financial Results And Highlights Operational Progress
04/05/2022 22:58
May 4 (Reuters) - Fate Therapeutics Inc FATE.O :
* FATE THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS OPERATIONAL PROGRESS
* Q1 REVENUE $18.4 MILLION
* Q1 REVENUE VIEW $9.4 MILLION -- REFINITIV IBES DATA
* QTRLY NET LOSS PER COMMON SHARE, BASIC AND DILUTED $0.68
* Q1 EARNINGS PER SHARE VIEW $-0.77 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1VBDSX
Further company coverage: FATE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview